Registry for understanding heart failure in patients
The Türkiye Heart Failure (TURK-HF) Registry
This study is creating a detailed registry to help understand heart failure in patients so we can find better ways to treat it and improve their health outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Baskent University Academic / other |
| Locations | 1 site (Ankara, Ankara) |
| Trial ID | NCT06707220 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a comprehensive registry that captures the socio-demographic, clinical, and biological characteristics of patients with heart failure. By identifying barriers to the implementation of guideline-directed medical therapies, the study seeks to improve patient outcomes and reduce hospitalization and mortality rates associated with heart failure. The registry will include patients with various forms of heart failure, including de novo, chronic, and worsening conditions, across different ejection fraction categories. The data collected will help inform strategies for better management and treatment of heart failure in real-world settings.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years and older who have been diagnosed with heart failure.
Not a fit: Patients under 18 years of age will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and better outcomes for patients with heart failure.
How similar studies have performed: Other heart failure registries have shown success in improving patient outcomes by identifying barriers to treatment and enhancing guideline adherence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Presence of heart failure - Exclusion Criteria: Age \<18 years \-
Where this trial is running
Ankara, Ankara
- Baskent University — Ankara, Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Umut Kocabaş
- Email: umutkocabas@hotmail.com
- Phone: +905079974999
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.